The chromosomal translocation t(1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia, leads to RCC1::IRF4 fusion.

Saved in:
Bibliographic Details
Title: The chromosomal translocation t(1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia, leads to RCC1::IRF4 fusion.
Authors: Jayne S; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., López C; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Germany.; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Universitat de Barcelona, Barcelona, Spain., Put N; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium.; Department of Oncology, Hematology and Radiotherapy, Ziekenhuis Oost-Limburg, Genk, Belgium.; Limburgs Oncologisch Centrum, Genk, Belgium.; Faculty of Medicine and Life Sciences, UHasselt-Hasselt University, Diepenbeek, Belgium., Nagel I; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Germany., Lierman E; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium., Penas EMM; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Germany., Michaux L; Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium., Ahearne MJ; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Walter HS; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Bens S; Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein-Campus Kiel, Kiel, Germany.; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany., Drewes C; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany., Szczepanowski M; Hematopathology Section, Christian-Albrechts-University Kiel, Kiel, Germany.; Second Medicine Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Schlesner M; Bioinformatics and Omics Data Analytics (B240), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany., Rosenstiel P; Institute of Clinical Molecular Biology, Christian-Albrechts-University, Kiel, Germany., Wlodarska I; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Siebert R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany., Dyer MJS; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
Source: British journal of haematology [Br J Haematol] 2024 Dec; Vol. 205 (6), pp. 2321-2326. Date of Electronic Publication: 2024 Oct 15.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2141
DOI:10.1111/bjh.19790